S3 guidelines on the therapy of psoriasis vulgaris - Methods report;S3-Leitlinie zur Therapie der Psoriasis vulgaris - Methodenreport

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue SUPPL. 2, 2011, Pages

  Nast, Alexander ^a   Rosumeck, Stefanie ^a   Sammain, Adel ^a   Erdmann, Ricardo ^a   Sporbeck, Birte ^a   Rzany, Berthold ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

biologics; evidence based S3 guidelines; methods report; psoriasis; systemic treatment; topical treatment; UV

Indexed keywords

ADALIMUMAB; CALCINEURIN INHIBITOR; COAL TAR; EFALIZUMAB; METHOTREXATE; RETINOID; USTEKINUMAB;

ARTICLE; EVIDENCE BASED MEDICINE; GERMANY; MEDICAL SOCIETY; METHODOLOGY; PRACTICE GUIDELINE; PSORIASIS VULGARIS;

DERMATOLOGY; GERMANY; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSORIASIS;

EID: 79958181054     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0379.2011.07682.x     Document Type: Article

References (15)

1. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003; 362: 1225-30. (Pubitemid 37255352)
2. Nast A, Kopp I, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B. German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version). Arch Dermatol Res 2007; 299: 111-38. (Pubitemid 46835379)
3. Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski HD, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B. [S3-Guidelines for the therapy of psoriasis vulgaris]. J Dtsch Dermatol Ges 2006; 4 Suppl 2: S1-126.
4. Nast A, Augustin M, Boehncke WH, Klaus J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Schlaeger M, Sebastian M, Sterry W, Streit V, Weisenseel P, Rzany B. Evidence- based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab". J Dtsch Dermatol Ges 2010; 8: 65-6.
5. Leitlinien-Manual von AWMF und ÄZQ. Z ärztl Fortbild Qualsich (ZaeFQ) 2001; 95.
6. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003; 12: 18-23.
7. Deutsches Instrument zur methodischen Leitlinien-Bewertung (DELBI) Fassung 2005/2006 + Domäne 8. 2008. URL: http://www.delbi.de, last accessed on 03.09.2010
8. Nast A, Spuls PH, Ormerod AD, Reytan N, Saiag PH, Smith CH, Rzany B. A critical appraisal of evidence- based guidelines for the treatment of psoriasis vulgaris: 'AGREEing' on a common base for European evidence-based psoriasis treatment guidelines. J Eur Acad Dermatol Venereol 2009; 23: 782-7.
9. Spuls PH, Nast A. Evaluation of and perspectives on guidelines: what is important? J Invest Dermatol 2010; 130(10): 2348-9.
10. Tan JK, Wolfe BJ, Bulatovic R, Jones EB, Lo AY. Critical appraisal of quality of clinical practice guidelines for treatment of psoriasis vulgaris, 2006-2009. J Invest Dermatol 2010; 130(10): 2389-95.
11. Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Honigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 Suppl 2: 1-70.
12. Rote Liste Verlag. Pharmako-Ökonomische Angaben.
13. Prinz JC. [The EMEA suspends approval of Raptiva for psoriasis. Commentary]. Hautarzt 2009; 60: 345-6.
14. Nast A, Erdmann R, Hofelich V, Reytan N, Orawa H, Sterry W, Rzany B. Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines. Archives of Dermatology Research 2009; 301: 553-9.
15. Nast A, Rzany B. Three years after the publication of the German (S3) evidence based Psoriasis Guidelines - was it worth the effort? J Dtsch Dermatol Ges 2009; 7: 1044-7.